These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23976947)

  • 21. Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells.
    Kyu SY; Kobie J; Yang H; Zand MS; Topham DJ; Quataert SA; Sanz I; Lee FE
    J Immunol Methods; 2009 Jan; 340(1):42-7. PubMed ID: 18996127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
    J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
    Kositanont U; Wongsurakiat P; Pooruk P; Maranetra N; Puthavathana P
    Viral Immunol; 2010 Jun; 23(3):329-34. PubMed ID: 20565296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
    Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W; Kirkpatrick E; Ermler M; Nachbagauer R; Broecker F; Krammer F; Palese P
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.
    Wheatley AK; Kristensen AB; Lay WN; Kent SJ
    Sci Rep; 2016 May; 6():26478. PubMed ID: 27220898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
    Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses.
    Hirano D; Ohshima N; Kubota-Koketsu R; Yamasaki A; Kurosawa G; Okuno Y; Yoshida S; Kurosawa Y
    J Immunol Res; 2018; 2018():7251793. PubMed ID: 29854845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.
    Moody MA; Zhang R; Walter EB; Woods CW; Ginsburg GS; McClain MT; Denny TN; Chen X; Munshaw S; Marshall DJ; Whitesides JF; Drinker MS; Amos JD; Gurley TC; Eudailey JA; Foulger A; DeRosa KR; Parks R; Meyerhoff RR; Yu JS; Kozink DM; Barefoot BE; Ramsburg EA; Khurana S; Golding H; Vandergrift NA; Alam SM; Tomaras GD; Kepler TB; Kelsoe G; Liao HX; Haynes BF
    PLoS One; 2011; 6(10):e25797. PubMed ID: 22039424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune history profoundly affects broadly protective B cell responses to influenza.
    Andrews SF; Huang Y; Kaur K; Popova LI; Ho IY; Pauli NT; Henry Dunand CJ; Taylor WM; Lim S; Huang M; Qu X; Lee JH; Salgado-Ferrer M; Krammer F; Palese P; Wrammert J; Ahmed R; Wilson PC
    Sci Transl Med; 2015 Dec; 7(316):316ra192. PubMed ID: 26631631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody Determinants of Influenza Immunity.
    Crowe JE
    J Infect Dis; 2019 Apr; 219(Suppl_1):S21-S29. PubMed ID: 30715373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis.
    Li X; Vanitha DJ; Joo HM; He Y; Rouse BT; Sangster MY
    J Immunol Methods; 2006 Jun; 313(1-2):110-8. PubMed ID: 16730022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of adjuvants on the amount, specificity and functional activity of antibody response to human influenza vaccine in mice.
    Voutssas-Lara J; Cervantes-Torres J; Hernández M; Bobes RJ; Lamoyi E; Vázquez-Ramírez RA; Mendoza L; Reyes-Barrera KL; López-Martínez R; Alpuche-Solís ÁG; Rosales-Mendoza S; Huerta L; Fragoso G; Sciutto E
    Mol Immunol; 2021 Jul; 135():398-407. PubMed ID: 34022515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
    de Vries RD; Nieuwkoop NJ; Krammer F; Hu B; Rimmelzwaan GF
    Virus Res; 2020 Feb; 277():197839. PubMed ID: 31837382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.